Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Keating

Showing results (331-340 of 436) with videos related to

Pageof 44
Sort By:
Blood|November 1, 1988
Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemiaH M Kantarjian, R S Walters, T L Smith, et al.
Cancer|March 1, 1984
Prognostic factors in hairy cell leukemia (leukemic reticuloendotheliosis)D J Stewart, T L Smith, M J Keating, et al.
Blood|May 1, 1985
A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22)R Holmes, M J Keating, A Cork, et al.
Cancer|August 15, 1988
Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinosideH M Kantarjian, R S Walters, M J Keating, et al.
The New England Journal of Medicine|September 25, 1980
Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determinationG M Mavlight, S E Stuckey, F F Cabanillas, et al.
CA: a Cancer Journal for Clinicians|January 1, 1977
Acute leukemia in adults, 1977M J Keating, E J Freireich, K B McCredie, et al.
Blood|August 8, 1998
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapyM J Keating, S O'Brien, S Lerner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemiaH M Kantarjian, M J Keating, K B McCredie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabineH M Kantarjian, M J Keating, E H Estey, et al.
Pageof 44

Showing results (331-340 of 436) with videos related to

Sort By:
Pageof 44
Blood|November 1, 1988
Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemiaH M Kantarjian, R S Walters, T L Smith, et al.
Cancer|March 1, 1984
Prognostic factors in hairy cell leukemia (leukemic reticuloendotheliosis)D J Stewart, T L Smith, M J Keating, et al.
Blood|May 1, 1985
A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22)R Holmes, M J Keating, A Cork, et al.
Cancer|August 15, 1988
Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinosideH M Kantarjian, R S Walters, M J Keating, et al.
The New England Journal of Medicine|September 25, 1980
Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determinationG M Mavlight, S E Stuckey, F F Cabanillas, et al.
CA: a Cancer Journal for Clinicians|January 1, 1977
Acute leukemia in adults, 1977M J Keating, E J Freireich, K B McCredie, et al.
Blood|August 8, 1998
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapyM J Keating, S O'Brien, S Lerner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemiaH M Kantarjian, M J Keating, K B McCredie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabineH M Kantarjian, M J Keating, E H Estey, et al.
Pageof 44